These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 15890582)
21. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments. Booth J; Zavgorodni S Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241 [TBL] [Abstract][Full Text] [Related]
22. A failure detection strategy for intrafraction prostate motion monitoring with on-board imagers for fixed-gantry IMRT. Liu W; Luxton G; Xing L Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):904-11. PubMed ID: 20579818 [TBL] [Abstract][Full Text] [Related]
23. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Kotte AN; Hofman P; Lagendijk JJ; van Vulpen M; van der Heide UA Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):419-25. PubMed ID: 17513059 [TBL] [Abstract][Full Text] [Related]
24. An endorectal balloon reduces intrafraction prostate motion during radiotherapy. Smeenk RJ; Louwe RJ; Langen KM; Shah AP; Kupelian PA; van Lin EN; Kaanders JH Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):661-9. PubMed ID: 22099035 [TBL] [Abstract][Full Text] [Related]
26. Impact of geometric uncertainties on evaluation of treatment techniques for prostate cancer. Craig T; Wong E; Bauman G; Battista J; Van Dyk J Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):426-36. PubMed ID: 15890584 [TBL] [Abstract][Full Text] [Related]
27. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Vargas C; Mahajan C; Fryer A; Indelicato D; Henderson RH; McKenzie C; Horne D; Chellini A; Lawlor P; Li Z; Oliver K; Keole S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1110-6. PubMed ID: 17967305 [TBL] [Abstract][Full Text] [Related]
28. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy? Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377 [TBL] [Abstract][Full Text] [Related]
29. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066 [TBL] [Abstract][Full Text] [Related]
30. Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer. Ronson BB; Yonemoto LT; Rossi CJ; Slater JM; Slater JD Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1367-70. PubMed ID: 16488552 [TBL] [Abstract][Full Text] [Related]
31. [Prostate localization systems for prostate radiotherapy]. de Crevoisier R; Lagrange JL; Messai T; M'Barek B; Lefkopoulos D Cancer Radiother; 2006 Nov; 10(6-7):394-401. PubMed ID: 17035061 [TBL] [Abstract][Full Text] [Related]
32. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094 [TBL] [Abstract][Full Text] [Related]
33. Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy. de Leon J; Jameson MG; Rivest-Henault D; Keats S; Rai R; Arumugam S; Wilton L; Ngo D; Liney G; Moses D; Dowling J; Martin J; Sidhom M Br J Radiol; 2019 Jun; 92(1098):20190056. PubMed ID: 30912956 [TBL] [Abstract][Full Text] [Related]
34. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio. Hille A; Töws N; Schmidberger H; Hess CF Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789 [TBL] [Abstract][Full Text] [Related]
35. Measurement of intrafractional prostate motion using magnetic resonance imaging. Mah D; Freedman G; Milestone B; Hanlon A; Palacio E; Richardson T; Movsas B; Mitra R; Horwitz E; Hanks GE Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):568-75. PubMed ID: 12243837 [TBL] [Abstract][Full Text] [Related]
36. A study to quantify the effectiveness of daily endorectal balloon for prostate intrafraction motion management. Wang KK; Vapiwala N; Deville C; Plastaras JP; Scheuermann R; Lin H; Bar Ad V; Tochner Z; Both S Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1055-63. PubMed ID: 22115790 [TBL] [Abstract][Full Text] [Related]
37. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Mock U; Bogner J; Georg D; Auberger T; Pötter R Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838 [TBL] [Abstract][Full Text] [Related]